Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

WN Pharmaceuticals Ltd products

Canada Type II Ongoing · initiated 2024-07-29

Product safety. Verify if your product is affected. If yes, stop using the recalled product. Consult your healthcare practitioner if you have used the affected …

Eugia US LLC

US Class II Ongoing · initiated 2024-07-26

Presence of Particulate Matter: Complaint received of a glass particle in the vial.

JAMP Pantoprazole Sodium

Canada Type II Ongoing · initiated 2024-07-25

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

B. Braun Medical Inc

US Class I Ongoing · initiated 2024-07-24

Presence of Particulate Matter

FDC Limited

US Class II Ongoing · initiated 2024-07-23

Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2024-07-22

CGMP Deviations

Granules Consumer Health Inc.

US Class III Terminated · initiated 2024-07-18

Label mix-up: Carton incorrectly labeled.

MAIN PRODUCTS INC

US Class I Ongoing · initiated 2024-07-18

Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

FDC Limited

US Class II Ongoing · initiated 2024-07-18

Defective container; yellow colored spike from cap lodged in the nozzle

Luscious Eyelash & Eyebrow Growth Serum

Canada Type II Ongoing · initiated 2024-07-16

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

SoloVital

US Class I Ongoing · initiated 2024-07-12

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Supercore Products Group Inc.

US Class I Ongoing · initiated 2024-07-12

Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.

Supercore Products Group Inc.

US Class I Ongoing · initiated 2024-07-12

Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.

Aurobindo Pharma USA Inc

US Class I Ongoing · initiated 2024-07-11

Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

Endo Pharmaceuticals, Inc.

US Class I Terminated · initiated 2024-07-10

Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton r…

SUN PHARMACEUTICAL INDUSTRIES INC

US Class II Terminated · initiated 2024-07-09

Failed Dissolution Specifications

Hikma Pharmaceuticals USA Inc.

US Class I Ongoing · initiated 2024-07-08

Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per…

Budesonide, USP

Canada Type II Ongoing · initiated 2024-07-04

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Novel Laboratories, Inc. d.b.a Lupin Somerset

US Class III Terminated · initiated 2024-07-02

Defective container: potential for non-sealed pouches which can lead to product leakage.

Cipla Omnigel Spray

Canada Type II Ongoing · initiated 2024-07-02

Unauthorized product. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any heal…

Uriexo

Canada Type III Ongoing · initiated 2024-07-02

Unauthorized product. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any heal…

Teva Pharmaceuticals USA, Inc

US Class II Ongoing · initiated 2024-06-28

Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification li…

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2024-06-28

Failed Dissolution Specifications: results below specifications

Zydus Pharmaceuticals (USA) Inc

US Class II Terminated · initiated 2024-06-27

Presence of particulate matter: glass

Suntegrity Impeccable Skin Sunscreen Foundation

Canada Type II Ongoing · initiated 2024-06-27

Contamination. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health conc…